RESEARCHER PROFILE

Walter Berger

← Back to Medical University of Vienna

W

Medical University of Vienna

Metal complexes synthesis and propertiesGlioma Diagnosis and TreatmentOccupational and environmental lung diseasesFibroblast Growth Factor ResearchLung Cancer Treatments and Mutations

Walter Berger works in Metal complexes synthesis and properties, Glioma Diagnosis and Treatment, Occupational and environmental lung diseases, Fibroblast Growth Factor Research, Lung Cancer Treatments and Mutations. Recorded institutional associations include Vienna General Hospital, Comprehensive Cancer Center Vienna, Center for Cancer Research.

788Publications
20,864Citations
71H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

    2016 · 975 citations
  2. KP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients

    2008 · 830 citations
  3. NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

    2014 · 675 citations
  4. Anticancer Activity of Metal Complexes: Involvement of Redox Processes

    2011 · 554 citations
  5. Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development

    2017 · 425 citations
  6. Metal Drugs and the Anticancer Immune Response

    2018 · 354 citations
  7. Green tea extract and (−)‐epigallocatechin‐3‐gallate, the major tea catechin, exert oxidant but lack antioxidant activities

    2005 · 313 citations
  8. Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity

    2008 · 253 citations
  9. Spatio‐temporally precise activation of engineered receptor tyrosine kinases by light

    2014 · 245 citations
  10. Resistance against novel anticancer metal compounds: Differences and similarities

    2008 · 242 citations
  11. Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism

    2017 · 231 citations
  12. Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells

    2004 · 200 citations
  13. Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity

    2013 · 183 citations
  14. Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339

    2010 · 173 citations
  15. Impact of Metal Coordination on Cytotoxicity of 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone (Triapine) and Novel Insights into Terminal Dimethylation

    2009 · 162 citations
  16. Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric Ependymoma

    2020 · 155 citations
  17. Structure−Activity Relationship Analysis of Novel Derivatives of Narciclasine (an Amaryllidaceae Isocarbostyril Derivative) as Potential Anticancer Agents

    2009 · 152 citations
  18. Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds

    2011 · 151 citations
  19. Anticancer metal drugs and immunogenic cell death

    2016 · 144 citations
  20. Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity

    2013 · 141 citations
  21. Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action

    2015 · 141 citations
  22. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications

    2005 · 140 citations
  23. TERTpromoter mutations are associated with poor prognosis and cell immortalization in meningioma

    2018 · 140 citations
  24. Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24)

    2005 · 137 citations
  25. An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo

    2016 · 135 citations

← Return to the university profile